벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires théa - phenylephrine hydrochloride 1,5 g/10 ml - eye drops, solution - 150 mg/ml - phenylephrine hydrochloride 150 mg/ml - phenylephrine

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoire aguettant - phenylephrine hydrochloride 60,9 µg/ml - eq. phenylephrine 50 µg/ml - solution for injection in pre-filled syringe - 50 µg/ml - phenylephrine hydrochloride 60.9 µg/ml - phenylephrine

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

unimedic pharma ab - phenylephrine hydrochloride 0,061 mg/ml - eq. phenylephrine 0,05 mg/ml - solution for injection - 0,05 mg/ml - phenylephrine hydrochloride 0.061 mg/ml - phenylephrine

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

unimedic pharma ab - phenylephrine hydrochloride 0,122 mg/ml - eq. phenylephrine 0,1 mg/ml - solution for injection - 0,1 mg/ml - phenylephrine hydrochloride 0.122 mg/ml - phenylephrine

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

unimedic pharma - phenylephrine hydrochloride - solution for injection - 0,1 mg/ml - phenylephrine hydrochloride 0.122 mg/ml - phenylephrine

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

unimedic pharma ab - phenylephrine hydrochloride 12,2 mg/ml - eq. phenylephrine 10 mg/ml - concentrate for solution for injection/infusion - 10 mg/ml - phenylephrine hydrochloride 12.2 mg/ml - phenylephrine

미국 - 영어 - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. none risk summary data from randomized controlled trials and meta-analyses with phenylephrine hydrochloride injection use in pregnant women during cesarean section have not established a drug-associated risk of major birth defects and miscarriage. these studies have not identified an adverse effect on maternal outcomes or infant apgar scores [see data] . there are no data on the use of phenylephrine hydrochloride during the first or second trimester. in animal reproduction and development studies in normotensive animals, evidence of fetal malformations was noted when phenylephrine hydrochloride was administered during organogenesis via a 1-hour infusion at 1.2 times the human daily dose (hdd) of 10 mg/60 kg/day. decreased pup weights were noted in offspring of pregnant rats treated with 2.9 times the hdd [see data]. the estimated backgrou

미국 - 영어 - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride injection 10 mg per ml is indicated for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation in the settings of anesthesia and septic shock. the use of phenylephrine hydrochloride injection 10 mg per ml is contraindicated in patients with: - hypersensitivity to the products or any of their components risk summary in animal reproductive and developmental studies, decreased fetal body weights were noted at 0.4 times the human daily dose (hdd) of 10 mg. no malformations were reported, however, an increased incidence of agenesis of the intermediate lobe of the lung, a visceral variation, was reported at levels as low as 0.08 times the hdd. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and misca

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoire aguettant - phenylephrine hydrochloride 0,122 mg/ml - eq. phenylephrine 0,1 mg/ml - solution for injection/infusion - 100 µg/ml - phenylephrine hydrochloride 0.122 mg/ml - phenylephrine

미국 - 영어 - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. none risk summary data from randomized controlled trials and meta-analyses with phenylephrine hydrochloride injection use in pregnant women during cesarean section have not established a drug-associated risk of major birth defects and miscarriage. these studies have not identified an adverse effect on maternal outcomes or infant apgar scores [see data] . there are no data on the use of phenylephrine during the first or second trimester. in animal reproduction and development studies in normotensive animals, evidence of fetal malformations was noted when phenylephrine was administered during organogenesis via a 1-hour infusion at 1.2 times the human daily dose (hdd) of 10 mg/60 kg/day. decreased pup weights were noted in offspring of pregnant rats treated with 2.9 times the hdd [see data]. the estimated background risk of major birth defec